Camber Capital Management LP 13D and 13G filings for PTC Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 08:35 am Sale | 2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT | Camber Capital Management LP | 3,200,000 4.150% | -800,000 (-20.00%) | Filing |
| 2023-10-30 09:05 am Purchase | 2023-10-19 | 13G | PTC Therapeutics, Inc. PTCT | Camber Capital Management LP | 4,000,000 5.310% | 4,000,000 (New Position) | Filing |